1. Home
  2. SR vs RYTM Comparison

SR vs RYTM Comparison

Compare SR & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SR
  • RYTM
  • Stock Information
  • Founded
  • SR 1857
  • RYTM 2008
  • Country
  • SR United States
  • RYTM United States
  • Employees
  • SR N/A
  • RYTM N/A
  • Industry
  • SR Oil/Gas Transmission
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SR Utilities
  • RYTM Health Care
  • Exchange
  • SR Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • SR 4.4B
  • RYTM 3.8B
  • IPO Year
  • SR N/A
  • RYTM 2017
  • Fundamental
  • Price
  • SR $77.96
  • RYTM $62.97
  • Analyst Decision
  • SR Buy
  • RYTM Strong Buy
  • Analyst Count
  • SR 9
  • RYTM 12
  • Target Price
  • SR $77.44
  • RYTM $74.92
  • AVG Volume (30 Days)
  • SR 470.2K
  • RYTM 961.2K
  • Earning Date
  • SR 04-30-2025
  • RYTM 05-07-2025
  • Dividend Yield
  • SR 4.02%
  • RYTM N/A
  • EPS Growth
  • SR 8.67
  • RYTM N/A
  • EPS
  • SR 4.04
  • RYTM N/A
  • Revenue
  • SR $2,505,500,000.00
  • RYTM $130,126,000.00
  • Revenue This Year
  • SR $6.59
  • RYTM $43.84
  • Revenue Next Year
  • SR $4.12
  • RYTM $65.62
  • P/E Ratio
  • SR $19.30
  • RYTM N/A
  • Revenue Growth
  • SR N/A
  • RYTM 68.06
  • 52 Week Low
  • SR $57.77
  • RYTM $35.17
  • 52 Week High
  • SR $79.81
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • SR 58.07
  • RYTM 62.41
  • Support Level
  • SR $76.85
  • RYTM $59.03
  • Resistance Level
  • SR $78.48
  • RYTM $62.85
  • Average True Range (ATR)
  • SR 2.32
  • RYTM 4.28
  • MACD
  • SR 0.13
  • RYTM 0.46
  • Stochastic Oscillator
  • SR 86.30
  • RYTM 98.61

About SR Spire Inc.

Spire Inc is a public utility holding company with three reportable business segments: Gas Utility, Gas Marketing and Midstream. The Gas Utility segment includes the regulated operations of Laclede Gas, Alabama Gas Corporation ('Alagasco') changed its name to Spire Alabama Inc. effective September 1, 2017, and Laclede Gas Company changed its name to Spire Missouri Inc. effective August 30, 2017. The Gas Utility segment generates a majority of the company's revenue but is subject to seasonal fluctuations. The Gas Marketing segment includes Laclede Energy Resources, Inc, whose operations include the marketing of natural gas and related activities on a non-regulated basis and the Midstream segment includes transportation and storage of natural gas. Maximum revenue from residential area.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: